DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $672,103 | +161.7% | 2,709 | +153.2% | 0.06% | +162.5% |
| Q2 2023 | $256,800 | +185.3% | 1,070 | +248.5% | 0.02% | -7.7% |
| Q1 2022 | $90,000 | -9.1% | 307 | +1.7% | 0.03% | 0.0% |
| Q4 2021 | $99,000 | -66.2% | 302 | -68.6% | 0.03% | -65.3% |
| Q3 2021 | $293,000 | +244.7% | 963 | +202.8% | 0.08% | +240.9% |
| Q2 2021 | $85,000 | +25.0% | 318 | +5.3% | 0.02% | +10.0% |
| Q1 2021 | $68,000 | +1.5% | 302 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $67,000 | -58.4% | 302 | -59.5% | 0.02% | -56.5% |
| Q3 2020 | $161,000 | +17.5% | 746 | -3.4% | 0.05% | -11.5% |
| Q2 2020 | $137,000 | +28.0% | 772 | 0.0% | 0.05% | +30.0% |
| Q1 2020 | $107,000 | -10.1% | 772 | -0.6% | 0.04% | -7.0% |
| Q4 2019 | $119,000 | +95.1% | 777 | +82.8% | 0.04% | +59.3% |
| Q3 2019 | $61,000 | -99.8% | 425 | +120.2% | 0.03% | +92.9% |
| Q2 2019 | $27,584,000 | +33133.7% | 193 | -69.1% | 0.01% | -60.0% |
| Q1 2019 | $83,000 | +29.7% | 625 | 0.0% | 0.04% | +52.2% |
| Q4 2018 | $64,000 | -9.9% | 625 | -4.9% | 0.02% | -20.7% |
| Q3 2018 | $71,000 | +10.9% | 657 | 0.0% | 0.03% | +7.4% |
| Q2 2018 | $64,000 | -49.2% | 657 | -48.8% | 0.03% | -49.1% |
| Q1 2018 | $126,000 | +4.1% | 1,282 | +7.2% | 0.05% | -1.9% |
| Q4 2017 | $121,000 | +108.6% | 1,196 | +77.2% | 0.05% | +157.1% |
| Q3 2017 | $58,000 | +16.0% | 675 | +5.3% | 0.02% | -43.2% |
| Q4 2016 | $50,000 | – | 641 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |